CoChat

A randomized, double‐blind, fixed‐dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder

Mahableshwarkar, Atul R., Jacobsen, Paula L., Serenko, Michael, Chen, Yinzhong · 2014 · Human Psychopharmacology: Clinical and Experimental
Cited by 44

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

Abstract

Background: Vortioxetine is a recently approved multimodal antidepressant with anxiolytic properties in preclinical studies. Objective: This double‐blind, placebo‐controlled study assessed the efficacy and tolerability of vortioxetine in subjects with a primary diagnosis of generalized anxiety disorder. Methods: Subjects (n = 457) were randomized 1:1:1 to treatment with placebo or vortioxetine 2.5 or 10 mg once daily. The primary efficacy endpoint was reduction in Hamilton Anxiety Scale (HAM‐A) total scores from baseline after 8 weeks of treatment. Key secondary outcomes were changes from baseline in HAM‐A total scores for the 2.5 and 10 mg dose, Hospital Anxiety and Depression anxiety subscore, 36‐Item Short‐Form Health Survey, Sheehan Disability Scale, and Clinical Global Impression‐Improvement Scale score, as well as HAM‐A response rate at week 8. Results: Neither vortioxetine dose achieved a statistically significant improvement over placebo on the primary endpoint (least‐squares mean difference ± standard error from placebo: –0.87 ± 0.803 [p = 0.279] for 2.5 mg and −0.81 ± 0.791 [p = 0.306] for 10 mg vortioxetine) or on any secondary efficacy endpoints. Common adverse events (≥5% in either vortioxetine group) were nausea, dry mouth, headache, diarrhea, constipation, and vomiting. Conclusions: Vortioxetine 2.5 and 10 mg treatment did not significantly improve generalized anxiety disorder symptoms versus placebo. Vortioxetine was safe and well tolerated in this patient population. Copyright © 2014 John Wiley & Sons, Ltd.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/hup.2371

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Cited by

See all 44

Metadata

Authors
Mahableshwarkar, A. R., Jacobsen, P. L., Serenko, M., & Chen, Y.
Venue
Human Psychopharmacology: Clinical and Experimental
Publisher
Wiley
Published
2014-01
Volume
29
Issue
1
Pages
64-72
ISSN
  • 0885-6222 (ISSN-L)
  • 1099-1077
OpenAlex
W2129162473
Cited by
44
References
8
FWCI
5.19
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: A randomized, double‐blind, fixed‐dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder. https://app.cochat.ai/papers/10.1002/hup.2371
The paper
Mahableshwarkar, A. R., Jacobsen, P. L., Serenko, M., & Chen, Y. (2014). A randomized, double‐blind, fixed‐dose study comparing the efficacy and tolerability of vortioxetine 2.5 and 10 mg in acute treatment of adults with generalized anxiety disorder. Human Psychopharmacology: Clinical and Experimental. https://doi.org/10.1002/hup.2371

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.